CA 125 Test Market Report 2025 (Global Edition)

Global CA 125 Test Market Report 2025 Market Size Split by Device & Accessory (Spectrometer, Analyzer, Sample Collection Tubes, Otopic Labelled Peptides, Others), by Indication (Cancer, Ovarian cancer...

CA 125 Test Market Report Description

We have various report editions of CA 125 Test Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Ca 125 test Market

The competitive landscape of the CA 125 test market is characterized by a mix of established players and emerging companies offering a range of products and services related to ovarian cancer diagnostics. Key players in the market include established diagnostic companies, biotechnology firms, and research institutions that have developed and commercialized CA 125 test kits and related products.

In December 2020, VALIDATE Tumour Markers have been discharged, according to LGC Maine Standards. This was done to satisfy the clinical laboratories' requirements for linearity and calibration verification. The Abbott Architect and Abbott Affinity systems are used in these labs.

(Source:https://www.prnewswire.com/news-releases/lgc-maine-standards-announces-validate-tumor-markers-kit-for-abbott-architect-and-abbott-alinity-with-analytes-cea-ca-125-ca-15-3-and-ca-19-9-for-easy-fast-and-reliable-documentation-of-linearity-calibration-verification-a-301187384.html)

In February 2022, BD's U.S. headquarters are in New Jersey. Becton, Dickinson and Company announced the acquisition of Cytognos.

(Source:https://news.bd.com/2022-02-01-BD-Expands-from-Cancer-Discovery-and-Diagnosis-into-Post-Treatment-Monitoring-with-Acquisition-of-Cytognos-from-Vitro-S-A)

Top Companies Market Share in CA 125 Test Industry: (In no particular order of Rank)

• Abbott Laboratories
• Bayer
• Eli Lilly Company
• Allergan plc
• Amgen Inc.
• Pfizer Inc.
• Merck & Co.
• Inc.
• Teva Pharmaceuticals Pvt. Ltd.
• AMAG Pharmaceuticals
• Johnson & Johnson
• Sanofi
• Novartis AG
• AbbVie Inc.
• GlaxoSmithKline plc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the CA 125 Test Market

Which Region Dominates the Ca 125 test Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. North America leads the CA 125 test market due to several key factors. First, the region has a well-established healthcare infrastructure and a high prevalence of ovarian cancer, for which the CA 125 test is primarily used. Second, North America has a strong presence of leading diagnostic companies and research institutions focused on developing advanced diagnostic tools, including cancer biomarker tests like CA 125. Third, favorable reimbursement policies and widespread awareness about ovarian cancer screening contribute to higher adoption rates of the CA 125 test in North America compared to other regions. Overall, these factors contribute to North America's dominance in the CA 125 test market.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific stands out as the fastest-growing region in the Ca 125 test market due to several compelling reasons. Firstly, the region has a large and growing population, leading to an increased prevalence of ovarian cancer and consequently, a higher demand for diagnostic tests like CA 125. Second, improving healthcare infrastructure and rising healthcare expenditure in countries across Asia Pacific are driving the adoption of advanced diagnostic technologies. Third, increasing awareness about women's health and proactive screening measures for early detection of ovarian cancer are further boosting the demand for the CA 125 test in the region. These factors combined contribute to Asia Pacific being the fastest-growing region in the CA 125 test market.

The current report Scope analyzes CA 125 Test Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America CA 125 Test

According to Cognitive Market Research, the global Ca 125 test market size was estimated at USD 815.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 326.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Ca 125 test market with a market size of USD 257.28 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The demand is amplified by the nation's growing awareness about early cancer detection, and advancements in diagnostic technologies propel consistent growth.
• The Canada Ca 125 test market had a market share of USD 39.13 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Canada's advancements in diagnostic technologies to increased usage of Ca 125 test.
• The Mexico Ca 125 test market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD 29.67 million in 2024.

Europe CA 125 Test

According to Cognitive Market Research, the global Ca 125 test market size was estimated at USD 815.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 244.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.

• The United Kingdom Ca 125 test market had a market share of USD 41.09 million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. In the UK, Ca 125 test sales witness an upswing due to the nation's increasing awareness about cancer screening, advancements in diagnostic technologies.
• The France Ca 125 test market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD 22.50 million in 2024.
• According to Cognitive Market Research, the Germany Ca 125 test market size was valued at USD 48.42 million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period. In Germany, Ca 125 test sales surge due to the advancements in diagnostic technologies.
• The Italy Ca 125 test market is projected to witness growth at a CAGR of 3.9% during the forecast period with a market size of USD 21.03 million in 2024.
• The Russia Ca 125 test market is projected to witness growth at a CAGR of 3.5% during the forecast period with a market size of USD 37.91 million in 2024.
• The Spain Ca 125 test market is projected to witness growth at a CAGR of 3.6% during the forecast period with a market size of USD 20.05 million in 2024.
• The Luxembourg Ca 125 test market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD 7.58 million in 2024.
• The Portugal Ca 125 test market is projected to witness growth at a CAGR of 4.3% during the forecast period with a market size of USD 5.14 million in 2024.
• The Greece Ca 125 test market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD 2.93 million in 2024.
• Rest of Europe Ca 125 test market is projected to witness growth at a CAGR of 3.2% during the forecast period with a market size of USD 37.91 million in 2024.

Asia Pacific CA 125 Test

According to Cognitive Market Research, the global Ca 125 test market size was estimated at USD 815.2Million out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD 187.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Ca 125 test market size was valued at USD 84.37 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Ca 125 test sales surge in China due to the nation's increasing cancer prevalence, expanding healthcare infrastructure, and growing awareness about early disease detection.
• The Japan Ca 125 test market is projected to witness growth at a CAGR of 6.5% during the forecast period with a market size of USD 25.87 million in 2024.
• The India Ca 125 test market had a market share of USD 22.50 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. The demand is augmented by India's growing awareness about early disease detection.
• The South Korea Ca 125 test market is projected to witness growth at a CAGR of 7.1% during the forecast period with a market size of USD 18.75 million in 2024.
• The Australia Ca 125 test market is projected to witness growth at a CAGR of 7.7% during the forecast period with a market size of USD 9.75 million in 2024.
• The South East Asia Ca 125 test market is projected to witness growth at a CAGR of 9.0% during the forecast period with a market size of USD 12.94 million in 2024.
• The Rest of Asia Pacific Ca 125 test market is projected to witness growth at a CAGR of 7.8% during the forecast period with a market size of USD 13.31 million in 2024.

South America CA 125 Test

According to Cognitive Market Research, the global Ca 125 test market size was estimated at USD 815.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 40.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Ca 125 test market size was valued at USD 17.45 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Ca 125 test sales flourish in Brazil due to the nation's increasing cancer incidence, improving healthcare infrastructure, and rising awareness about early cancer detection.
• The Argentina Ca 125 test market had a market share of USD 6.85 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. The demand is augmented by Argentina's rising awareness about early cancer detection.
• The Colombia Ca 125 test market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD 3.63 million in 2024.
• The Peru Ca 125 test market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 3.34 million in 2024.
• The Chile Ca 125 test market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 2.93 million in 2024.
• The Rest of Latin America Ca 125 test market is projected to witness growth at a CAGR of 4.5% during the forecast period with a market size of USD 6.56 million in 2024.

Middle East CA 125 Test

According to Cognitive Market Research, the global Ca 125 test market size was estimated at USD 815.2 Million out of which Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD 16.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.

• The GCC Countries Ca 125 test market is projected to witness growth at a CAGR of 6.5% during the forecast period with a market size of USD 6.98 million in 2024. Ca 125 test sales flourish due to the region's increasing cancer incidence, improving healthcare infrastructure, and rising awareness about early cancer detection.
• The Egypt Ca 125 test market is projected to witness growth at a CAGR of 6.0% during the forecast period with a market size of USD 1.71 million in 2024.
• The South Africa Ca 125 test market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD 2.58 million in 2024. Ca 125 test sales flourish in the South Africa due to the rising awareness about early cancer detection.
• The Turkey Ca 125 test market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD 1.40 million in 2024.
• The Nigeria Ca 125 test market is projected to witness growth at a CAGR of 4.8% during the forecast period with a market size of USD 1.71 million in 2024.
• The Rest of MEA Ca 125 test market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD 1.92 million in 2024.

CA 125 Test Market Analysis

Ca 125 test Market Device & Accessory Segment Analysis

According to Cognitive Market Research, the dominant category in the CA 125 test market for devices and accessories is the spectrometer segment. Spectrometers are essential for analyzing the levels of CA 125 in patient samples, providing precise and accurate results. These devices are widely used in clinical laboratories and healthcare facilities due to their ability to deliver reliable measurements quickly. Moreover, advancements in spectrometer technology have led to the development of portable and user-friendly devices, further driving their adoption in point-of-care settings.

the fastest-growing category in the CA 125 test market for devices and accessories is the analyzer segment. Analyzers are critical components of the CA 125 testing process, as they are used to automate and streamline the testing procedure, reducing human error and increasing efficiency. The growing prevalence of ovarian cancer and the need for early detection are driving the demand for analyzers that can deliver quick and reliable results. Additionally, advancements in analyzer technology, such as the integration of artificial intelligence and machine learning, are further fueling the growth of this segment.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of CA 125 Test Industry. Request a Free Sample PDF!

Ca 125 test Market Indication Segment Analysis

According to Cognitive Market Research, the dominant indication is cancer, specifically ovarian cancer. Ovarian cancer is one of the most common cancers among women, and CA 125 is a biomarker that is often elevated in the blood of patients with this type of cancer. As a result, the CA 125 test is frequently used as a diagnostic tool to aid in the detection and monitoring of ovarian cancer. The high prevalence of ovarian cancer and the importance of early detection contribute to the dominance of this indication in the CA 125 test market.

The fastest-growing indication in the CA 125 test market is uterine fibroids. Uterine fibroids are noncancerous growths that develop in the uterus and can cause symptoms such as heavy menstrual bleeding, pelvic pain, and frequent urination. While uterine fibroids are not typically associated with elevated CA 125 levels, there is growing interest in using the CA 125 test as a potential biomarker for monitoring the growth of fibroids and assessing treatment response.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

CA 125 Test End User Segment Analysis

According to Cognitive Market Research, hospitals are the dominant end user. Hospitals typically have a higher patient volume compared to clinics and diagnostic centers, leading to a greater demand for CA 125 tests. Moreover, hospitals often have more specialized medical staff and equipment, making them better equipped to handle the testing and diagnosis of complex conditions like cancer. Additionally, hospitals are often the primary point of care for patients with serious illnesses, further driving the demand for CA 125 tests in these settings.

The fastest-growing end user category in the CA 125 test market is diagnostic centers. Diagnostic centers are experiencing rapid growth due to several factors, including the increasing focus on preventive healthcare and the rise in awareness about the importance of early cancer detection. Diagnostic centers often offer a wide range of diagnostic tests, including cancer screening tests like the CA 125 test, in a convenient and accessible manner.

• Hospital
• Clinic
• Diagnostic Centers
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion